KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
1-Year Return
51.8%
This Quarter Return
+4.95%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$141M
AUM Growth
-$13.1M
(-8.5%)
Cap. Flow
-$2.01M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
66.07%
Holding
39
New
3
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$909K |
| 2 |
Abeona Therapeutics
ABEO
|
$356K |
| 3 |
Royal Gold
RGLD
|
$258K |
| 4 |
Alamos Gold
AGI
|
$239K |
| 5 |
CGAU
Centerra Gold
CGAU
|
$170K |
Top Sells
| 1 |
Equinox Gold
EQX
|
$3.79M |
| 2 |
SKE
Skeena Resources
SKE
|
$318K |
Sector Composition
| 1 | Healthcare | 54.97% |
| 2 | Materials | 30.41% |
| 3 | Consumer Staples | 1.78% |
| 4 | Industrials | 1.73% |
| 5 | Financials | 1.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wheaton Precious Metals
WPM
$47.3B
| $1.12M | 0.8% |
12,500
| – | – |
|
27
Northrop Grumman
NOC
$83.2B
| $1.08M | 0.77% |
2,165
| – | – |
|
28
Coeur Mining
CDE
$9.43B
| $852K | 0.61% |
96,132
| – | – |
|
|
MREO
29
Mereo BioPharma
MREO
$282M
| $706K | 0.5% |
260,470
| – | – |
|
30
Diageo
DEO
$61.3B
| $681K | 0.48% |
6,750
| – | – |
|
|
VRNA
31
Verona Pharma
VRNA
$9.2B
| $667K | 0.47% |
7,049
| – | – |
|
|
NEWP
32
New Pacific Metals
NEWP
$352M
| $650K | 0.46% |
485,000
| – | – |
|
|
HOOK
33
DELISTED
HOOKIPA Pharma
HOOK
| $626K | 0.44% |
498,625
| – | – |
|
|
34
Abeona Therapeutics
ABEO
$353M
| $356K | 0.25% |
+62,689
| New | +$356K |
|
|
CGAU
35
Centerra Gold
CGAU
$1.76B
| $170K | 0.12% |
+1,227,863
| New | +$170K |
|
36
Orchestra BioMed
OBIO
$148M
| $170K | 0.12% |
+455,128
| New | +$170K |
|
|
CRDL
37
Cardiol Therapeutics
CRDL
$91.3M
| $136K | 0.1% |
100,000
| – | – |
|
|
38
Equinox Gold
EQX
$7.65B
| – | – |
-550,811
| Closed | -$3.79M |
|